Neonatal TPN Starter Bag Recalled for Sterility Assurance Issues
Central Admixture Pharmacy Services recalls 558 bags of Neonatal TPN Starter Bag nationwide due to lack of sterility assurance identified during an FDA inspection.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of a parenteral nutrition product with lack of sterility assurance following an FDA inspection. No reported illnesses or hospitalizations are mentioned. This meets the rubric criterion for Score 3: a risk-of-harm product where injury has not yet been reported.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling Neonatal TPN Starter Bag (Amino Acids (Trophamine) 3%/Dextrose 10% with calcium, NDC 71285-0405-1) in 250 mL bags distributed nationwide. The recall affects 558 bags.
The recall was initiated due to lack of assurance of sterility. An FDA inspection called into question the sterility of these products, which are intended to be sterile for intravenous use in neonates.
Affected lot numbers and expiration dates are: Lot 37-893806 (Exp 04/28/2023), 37-894701 (Exp 04/30/2023), 37-895626 (Exp 05/05/2023), 37-897277 (Exp 05/12/2023), 37-899175 (Exp 05/19/2023), and 37-900971 (Exp 05/26/2023). Healthcare facilities and pharmacies should immediately stop distribution and quarantine affected bags.
Patients who may have received this product should contact their healthcare provider.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10% with CALCIUM, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0405-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot # 37-893806
- Exp 04/28/2023
- 37-894701
- Exp 04/30/2023
- 37-895626
- Exp 05/05/2023
- 37-897277
- Exp 05/12/2023
- 37-899175
- Exp 05/19/2023
- 37-900971
- Exp 05/26/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27